Kiniksa Pharmaceuticals
KNSA
KNSA
132 hedge funds and large institutions have $340M invested in Kiniksa Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 56 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
4.08% more ownership
Funds ownership: 87.31% → 91.39% (+4.1%)
24% less capital invested
Capital invested by funds: $444M → $340M (-$105M)
Holders
132
Holding in Top 10
–
Calls
$4.83M
Puts
$2.16M
Top Buyers
| 1 | +$13M | |
| 2 | +$7.75M | |
| 3 | +$7.09M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$3.31M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.83M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$6.39M | |
| 3 | -$3.66M | |
| 4 |
LPC
Lion Point Capital
New York
|
-$2.51M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.46M |